I understand that it may be in the best interest of shareholders to ensure that competitors or potential takeover companies are not able to acquire RAC shares too cheap.
However I am wondering where the funds are coming from to do this Buyback, when the money raised was specifically allocated to different Trials and Pillars.
Ann: Race Oncology Announces On-Market Share Buyback, page-67
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.56 |
Change
0.035(2.30%) |
Mkt cap ! $254.2M | |||
| Open | High | Low | Value | Volume |
| $1.55 | $1.57 | $1.53 | $38.77K | 24.91K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200 | $1.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.56 | 2049 | 2 |
View Market Depth
| Last trade - 10.21am 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.55 |
Change
0.035 ( 2.32 %) |
||||
| Open | High | Low | Volume | ||
| $1.53 | $1.56 | $1.53 | 954 | ||
| Last updated 10.46am 22/05/2024 ? | |||||
| RAC (ASX) Chart |